Renejix – Small Molecule CDMO (USA)
| Renejix’s Prime Pharma Solution offers the fastest route from clinical to commercial manufacturing. Through a proactive strategy, it evaluates production aspects in the early developmental stages. This approach aids in risk reduction by concurrently tackling potential obstacles, thus guaranteeing resilient processes spanning from clinical phases to product launch. |
Using Renejix for your pharmaceutical needs means getting your supplies easily, anywhere, anytime, in perfect condition. Download
Introduction Overcoming drug development challenges requires a science-driven approach enhanced by data-driven decision-making and working with the right contract development and manufacturing…
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…
Clinical manufacturing, an important step in the pharmaceutical world, plays a vital role in bringing new drugs to market. While the term…
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
